scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH
· Real-Time Price · USD
4.60
-0.35 (-7.07%)
At close: Aug 15, 2025, 3:59 PM
4.74
3.04%
After-hours: Aug 15, 2025, 07:07 PM EDT
scPharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -18.02M | -19.74M | -18.84M | -35.1M | -17.09M | -14.11M | -13.81M | -15.63M | -14.15M | -11.21M | -9.25M | -10.16M | -9.7M | -7.73M | -7.32M | -6.55M | -7.06M | -7.1M |
Depreciation & Amortization | 64K | 63K | 4K | -87K | 52K | 51K | 140K | 272K | 109K | 105K | 120K | 118K | 128K | 102K | 111K | 112K | 109K | 106K |
Stock-Based Compensation | 1.52M | 1.29M | 1.28M | 1.23M | 1.49M | 1.44M | 1.42M | 1.28M | 1.18M | 980K | 737K | 785K | 680K | 636K | 637K | 619K | 589K | 521K |
Other Working Capital | -105K | 775K | -30K | -4.02M | -917K | 422K | -646K | 411K | 717K | 5.08M | -1.69M | -5K | 622K | 187K | -1.18M | 798K | 262K | -119K |
Other Non-Cash Items | 2.83M | 1.47M | 2.21M | 20.86M | 1.78M | -2.6M | -822K | 559K | 524K | -1.03M | -964K | 75K | 76K | 118K | 148K | 147K | 57K | 206K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.56M | -663K | -597K | n/a | n/a | n/a | n/a | n/a | n/a | 5K | 115K | n/a |
Change in Working Capital | -2.5M | -224K | 164K | -4.31M | -6.46M | -2.48M | -515K | 734K | -1.2M | -5.34M | -2.48M | 988K | 1.64M | -494K | -676K | 502K | -79K | -2.35M |
Operating Cash Flow | -16.11M | -17.14M | -15.19M | -17.42M | -20.23M | -17.7M | -15.16M | -13.45M | -14.14M | -16.49M | -11.84M | -8.2M | -7.17M | -7.37M | -7.1M | -5.17M | -6.27M | -8.62M |
Capital Expenditures | n/a | n/a | -12K | -9K | n/a | n/a | -37K | n/a | -3K | n/a | -6K | -15K | n/a | -6K | -9K | -10K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.43M | n/a | n/a | -10.8M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38.92M | -11.67M | n/a | -46.89M | -1K | -7.86M | -12.78M | n/a | -1.02M | -4M | -4M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 1K | 29.32M | 26.5M | 16M | 21.1M | 7M | 3.9M | 10.8M | 7M | n/a | 4.5M | 10.55M | 9.4M | 16.7M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.43M | 7M | 6K | 10.8M | -861K | -12.78M | 10K | -10K | 5.4M | 12.71M |
Investing Cash Flow | n/a | n/a | -12K | -9K | 1K | 29.32M | 26.46M | -22.93M | 9.43M | 7M | -42.99M | 10.78M | -861K | -12.79M | 4.5M | 9.52M | 5.4M | 12.71M |
Debt Repayment | n/a | -972K | n/a | -4.23M | n/a | n/a | n/a | n/a | n/a | n/a | 37.3M | -2.5M | -2.5M | -2.5M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -5.54B | 5.55B | -166K | n/a | 4.72B | n/a | n/a | n/a | n/a | n/a | n/a | 81K | n/a | n/a | -81K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -624K | n/a | 52.92M | 21.09M | n/a | -166K | -345K | 68K | 277K | n/a | -465K | 23K | 84K | 21K | -2.5M | n/a | n/a | 9K |
Financial Cash Flow | -624K | -972K | -631K | 70.41M | 283K | 15K | 467K | 68K | 611K | 13.7M | 84.6M | -2.48M | -2.42M | -2.48M | -2.46M | n/a | n/a | -72K |
Net Cash Flow | -16.73M | -18.11M | -15.83M | 52.98M | -19.94M | 11.63M | 11.77M | -36.31M | -4.1M | 4.21M | 29.77M | 111K | -10.45M | -22.64M | -5.05M | 4.35M | -868K | 4.02M |
Free Cash Flow | -16.11M | -17.14M | -15.2M | -17.43M | -20.23M | -17.7M | -15.2M | -13.45M | -14.14M | -16.49M | -11.84M | -8.21M | -7.17M | -7.38M | -7.11M | -5.18M | -6.27M | -8.62M |